Jerome Durso

2018

In 2018, Jerome Durso earned a total compensation of $3.2M as Chief Operating Officer at Intercept Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$292,032
Option Awards$775,844
Salary$540,800
Stock Awards$1,554,326
Other$22,403
Total$3,185,406

Durso received $1.6M in stock awards, accounting for 49% of the total pay in 2018.

Durso also received $292K in non-equity incentive plan, $775.8K in option awards, $540.8K in salary and $22.4K in other compensation.

Rankings

In 2018, Jerome Durso's compensation ranked 3,620th out of 14,244 executives tracked by ExecPay. In other words, Durso earned more than 74.6% of executives.

ClassificationRankingPercentile
All
3,620
out of 14,244
75th
Division
Manufacturing
1,340
out of 5,759
77th
Major group
Chemicals And Allied Products
472
out of 2,122
78th
Industry group
Drugs
391
out of 1,811
78th
Industry
Pharmaceutical Preparations
301
out of 1,385
78th

Pay ratio

Jerome Durso's Pay$3,185,406
Median Employee's Pay$244,883
Pay Ratio

13

to 1

In 2018, the annual total compensation of Jerome Durso was $3,185,406.

The annual total compensation of the median employee at Intercept Pharmaceuticals was $244,883.

The ratio of Jerome Durso's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on April 30, 2019.

Durso's colleagues

We found four more compensation records of executives who worked with Jerome Durso at Intercept Pharmaceuticals in 2018.

2018

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

2018

Ryan Sullivan

Intercept Pharmaceuticals

General Counsel

2018

Gail Cawkwell

Intercept Pharmaceuticals

SVP, Medical Affairs, Safety & Pharmacovigilance

2018

Sandip Kapadia

Intercept Pharmaceuticals

Chief Financial Officer

News

You may also like